Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcbest (ARCB) Gains from Sales and Divestitures (2016 - 2025)

Arcbest (ARCB) has disclosed Gains from Sales and Divestitures for 15 consecutive years, with $123001.0 as the latest value for Q4 2025.

  • On a quarterly basis, Gains from Sales and Divestitures fell 78.46% to $123001.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $123001.0, a 78.46% decrease, with the full-year FY2025 number at $123001.0, down 78.46% from a year prior.
  • Gains from Sales and Divestitures was $123001.0 for Q4 2025 at Arcbest, down from $571050.0 in the prior quarter.
  • In the past five years, Gains from Sales and Divestitures ranged from a high of $601441.0 in Q4 2022 to a low of $123001.0 in Q4 2025.
  • A 5-year average of $423981.2 and a median of $442690.0 in 2021 define the central range for Gains from Sales and Divestitures.
  • Peak YoY movement for Gains from Sales and Divestitures: soared 49.6% in 2024, then plummeted 78.46% in 2025.
  • Arcbest's Gains from Sales and Divestitures stood at $442690.0 in 2021, then skyrocketed by 35.86% to $601441.0 in 2022, then crashed by 36.53% to $381724.0 in 2023, then skyrocketed by 49.6% to $571050.0 in 2024, then tumbled by 78.46% to $123001.0 in 2025.
  • Per Business Quant, the three most recent readings for ARCB's Gains from Sales and Divestitures are $123001.0 (Q4 2025), $571050.0 (Q4 2024), and $381724.0 (Q4 2023).